EIF2AK3 and diabetes mellitus: Chronic reduced PERK activity is detrimental, as seen from PERK mutations in Wolcott-Rallison syndrome, which causes early-onset diabetes, epiphyseal dysplasias and neurodegeneration [105,106,107].